logo

Miragen Therapeutics, Inc. (MGEN)



Trade MGEN now with
  Date
  Headline
7/10/2018 7:10:43 AM MiRagen Therapeutics Begins Phase 2 Clinical Trial Of MRG-201
5/18/2018 12:19:43 PM Wedbush Reiterates MIRAGEN THERAPEUTICS, INC. (MGEN) At Outperform With $19 Price Target
4/30/2018 2:06:36 PM Wedbush Reiterates MIRAGEN THERAPEUTICS, INC. (MGEN) At Outperform With $19 Price Target
3/28/2018 6:37:27 AM Wedbush Reiterates MIRAGEN THERAPEUTICS, INC. (MGEN) At Outperform With $19 Price Target
3/27/2018 7:03:04 AM MiRagen Announces Initiation Of Phase 1 Clinical Trial Of MRG-110
2/5/2018 6:07:34 AM MiRagen Therapeutics To Sell 7 Mln Shares In Underwritten Public Offering
1/5/2018 1:22:20 PM B. Riley FBR Initiates MIRAGEN THERAPEUTICS, INC. (MGEN) At Buy With $15.50 Price Target
1/5/2018 7:01:45 AM MiRagen Therapeutics Appoints Arlene Morris As Independent Board Member, Effective January 3
12/1/2017 6:57:56 AM Wedbush Reiterates MIRAGEN THERAPEUTICS, INC. (MGEN) At Outperform With $19.00 Price Target
12/1/2017 6:56:56 AM Wedbush Is Increasing MIRAGEN THERAPEUTICS, INC. (MGEN) 2018 Estimate To -1.29 From -1.74
12/1/2017 6:56:39 AM Wedbush Is Raising MIRAGEN THERAPEUTICS, INC. (MGEN) 2017 Estimate To -1.38 From -1.61
12/1/2017 6:55:52 AM Wedbush Is Increasing MIRAGEN THERAPEUTICS, INC. (MGEN) Q4 18 Rev. Estimate To 1631 M From 718 M
12/1/2017 6:55:39 AM Wedbush Is Increasing MIRAGEN THERAPEUTICS, INC. (MGEN) Q3 18 Rev. Estimate To 1631 M From 718 M
12/1/2017 6:55:24 AM Wedbush Is Increasing MIRAGEN THERAPEUTICS, INC. (MGEN) Q2 18 Rev. Estimate To 1631 M From 718 M
12/1/2017 6:55:13 AM Wedbush Is Raising MIRAGEN THERAPEUTICS, INC. (MGEN) Q1 18 Rev. Estimate To 1631 M From 718 M
12/1/2017 6:54:54 AM Wedbush Is Increasing MIRAGEN THERAPEUTICS, INC. (MGEN) 2018 Rev. Estimate To 6524 M From 2872 M
12/1/2017 6:54:33 AM Wedbush Is Raising MIRAGEN THERAPEUTICS, INC. (MGEN) 2017 Rev. Estimate To 4442 M From 2616 M
12/1/2017 6:54:02 AM Wedbush Is Increasing MIRAGEN THERAPEUTICS, INC. (MGEN) Q4 17 Rev. Estimate To 1631 M From 718.0 M
10/16/2017 7:05:13 AM Wedbush Reiterates MIRAGEN THERAPEUTICS, INC. (MGEN) At Outperform With $19 Price Target